Keywords: Australia, TGA, Prescription drugs, Evaluation, Registration, Consultation

Australia’s TGA consults on requirements for the Rx medicine streamlined submission process

Article | 8 February 2010

• Print This

Australia’s Therapeutic Goods Administration has completed a review of the prescription medicine evaluation process, with a number of areas for streamlining being identified. Prior to implementation of the new streamlined process the TGA is inviting external stakeholders to review the proposed changes and provide comment on the underlying requirements that have been developed to underpin the process.

In the modern regulatory environment health regulators around the world, such as the TGA, are being asked for greater transparency in their regulatory processes, earlier access to novel therapies and more cost effective regulatory processes. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.